companydata.dkcompanydata.dk

LIVINGCELL ApS: Financial statements 2020

CVR: 27205607

Source: annual report 2020, Danish Business Authority

01/07/2019 – 30/06/2020

LIVINGCELL ApS (CVR 27205607) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 297,750 and a net result of DKK 228,041 compared with DKK 516,146 the year before. That is a decrease of 55.5% compared with the year before. Equity in the 2020 report amounted to DKK 362,204. The solvency ratio was 59.8%.

Gross Profit
DKK 297,750
Profit/Loss
DKK 228,041
Equity
DKK 362,204
Total Assets
DKK 605,809

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-298 t.228 t.362 t.-
2019-669 t.516 t.649 t.-
2018-894 t.693 t.823 t.-
2017-972 t.759 t.960 t.-
2016-633 t.493 t.201 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is LIVINGCELL ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About LIVINGCELL ApS

LIVINGCELL ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Anders Bek-Pedersen. The board consists of Anders Bek-Pedersen (chair). The company is owned by BEK-PEDERSEN HOLDING ApS. The company has 0 employees (2004). In 2025, the company reported a gross profit of DKK -13,500 and a net result of DKK -6,542 compared with DKK -17,604 the year before. Equity in the 2025 report amounted to DKK 115,908.

Source: annual report 2025, Danish Business Authority